The weekly litigation news digest is live. Subscribe now

IP Verse

Methods Of Treating Antibody-Mediated Rejection In Organ Transplant Patients With C1-Esterase Inhibitor - EP3071219

The patent EP3071219 was granted to Shire Viropharma on Nov 14, 2018. The application was originally filed on Nov 21, 2014 under application number EP14809567A. The patent is currently recorded with a legal status of "Revoked".

EP3071219

SHIRE VIROPHARMA
Application Number
EP14809567A
Filing Date
Nov 21, 2014
Status
Revoked
Jan 8, 2025
Publication Date
Nov 14, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CSL INNOVATIONAug 14, 2019MEWBURN ELLISADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP1240904
INTERNATIONAL-SEARCH-REPORTWO2013041677
INTERNATIONAL-SEARCH-REPORTWO2014145519
OPPOSITIONEP1240904
OPPOSITIONWO2013041677
OPPOSITIONWO2014145519
OPPOSITIONWO2015077543

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents